Haematopoietic cell transplants in Latin America

Bone Marrow Transplantation

Volumn 51, Issue 7, 2016, Pages 898-905

  Gale, R P ^a   Seber, A ^b   Bonfim, C ^c   Pasquini, M ^d  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HOSPITAL SAMARITANO   (Brazil)

^c FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; BORTEZOMIB; BUSULFAN; FLUDARABINE; LENALIDOMIDE; MELPHALAN; POMALIDOMIDE; PROTEIN TYROSINE KINASE INHIBITOR; THIOTEPA; THYMOCYTE ANTIBODY;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; CORD BLOOD STEM CELL TRANSPLANTATION; CULTURAL FACTOR; DRUG COST; FUSARIOSIS; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE MANPOWER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HOSPITAL BED CAPACITY; HUMAN; INTERNATIONAL COOPERATION; LIVING DONOR; MULTIPLE MYELOMA; MYCOSIS; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PUBLICATION; RECURRENT DISEASE; REDUCED INTENSITY CONDITIONING; REGISTER; REIMBURSEMENT; REVIEW; SOCIOECONOMICS; SOUTH AND CENTRAL AMERICA; TREATMENT INDICATION; TROPICAL DISEASE; UNRELATED DONORS; VIRUS INFECTION; VIRUS REACTIVATION; ECONOMIC DEVELOPMENT; SOCIAL CHANGE; TRENDS; UTILIZATION;

ECONOMIC DEVELOPMENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LATIN AMERICA; SOCIAL CHANGE; SOCIOECONOMIC FACTORS;

EID: 84961391147     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2016.35     Document Type: Review

References (14)

1. Gratwohl A, Pasquini MC, Aljurf M, Atsuta Y, Baldomero H, Foeken L. One million haemopoietic stem-cell transplants: a retrospective observational study for the Worldwide Network for Blood and Marrow Transplantation (WBMT). Lancet Haematol 2015; 2: e91-e100
2. Carnot-Uria J. Achievements and perspectives of stem cell transplantation in Cuba. Rev Cubana Hematol Immunol Hemoter 2012; 28: 108-110
3. Ruiz-Arguelles GJ, Tarin-Arzaga LC, Gonzalez-Carillo ML, Gutierrez-Riveroll KI, Rangel-Malo R, Gutierrez-Aguirre CH, et al. Therapeutic choices in patients with Ph-positive CML living in Mexico in the tyrosine kinase inhibitor era: SCT or TKIs? Bone Marrow Transplant 2008; 42: 23-28
4. Nucci M, Garnica M, Gloria AB, Lehugeur DS, Dias VC, Palma LC, et al. Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil. Clin Microbiol Infect 2013; 19: 745-751
5. Machado CM, Martins TC, Colturato I, Souza M, Anderson JS, Souza MP. Epidemiology of neglected tropical diseases in transplant recipients. Review of the literature and experience of a Brazilian HSCT center. Rev Inst Med trop Sao Paulo 2009; 51: 309-324
6. Pasquini MC, Zhu X. Current use and outcome of hematopoietic stem cell transplantation. CIBMTR Summary Slides, 2014. Available at http://www.cibmtr.org
7. Gragert L, Eapen M, Williams E, Freeman J, Spellman S, Baitty R, et al. HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry. N Engl J Med 2014; 371: 339-348
8. Ruiz A, Ruiz-Argüelles GJ. A Mexican way to cope with stem cell grafting. Hematology 2012; 17: S195-S197
9. Gutiérrez-Aguirre CH, Gómez-De-León A, Alatorre-Ricardo J, Cantú-Rodríguez OG, González-Llano O, Jaime-Pérez JC, et al. Allogeneic peripheral blood stem cell transplantation using reduced-intensity conditioning in an outpatient setting in ABO-incompatible patients: are survival and graft-versus-host disease different? Transfusion 2014; 54: 1269-1277
10. González-Llano O, Rodríguez-Romo LN, Mancías-Guerra Mdel C, Tarín-Arzaga L, Jaime-Pérez JC, Herrera-Garza JL, et al. Feasibility of an outpatient HLA haploidentical stem cell transplantation program in children using a reduced-intensity conditioning regimen and CD3-CD19 depletion. Hematology 2014; 19: 10-17
11. Jaime-Pérez JC, Heredia-Salazar AC, Cantú-Rodríguez OG, Gutiérrez-Aguirre H, Villarreal-Villarreal CD, Mancías-Guerra C, et al. Cost structure and clinical outcome of a stem cell transplantation program in a developing country: the experience in Northeast Mexico. Oncologist 2015; 20: 386-392
12. Woolhandler S, Himmelstein DU, Labar B, Lang S. Transplanted technology: Third World options and First World science. N Engl J Med 1987; 317: 504-506
13. Galeano E. Open Veins of Latin America. Monthly Review Press: New York, NY, USA, 1997
14. Condino-Neto C, Sorensen RU, Gomez-Raccio AC, King A, Espinosa-Rosales FJ, Franco JL. Current state and future perspectives of the Latin American Society for Immunodeficiencies (LASID). http://dx.doi.org/10.1016/j.aller.2014.05.007